{"name":"Receptor Life Sciences","slug":"receptor-life-sciences","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiywJBVV95cUxNUEd6bmFmQWExTlVkNEhNcXFlLVEyem84bVZKT1ZxdXFlbDNuN3FhU1BzWE9hWU5Ja19PZEw3ZDJIWlV0S1NHRFBCVlJSV1NWODJ0M3Zhb2tQUWJpYUVnYk5qS05YYlZ2T2ExNjgwdmRyNkMwNndzbmpFQ1VieWp4YTRGSEFkek9xNjhrUFdWR0ctNE9UdGt1MjF2dTcxa2tQV3ZLTnJ3aWZhclNiTjRwZVBxX0g3NlVaVUFaT0NlOVlrTG1QcFFaMmx3NkFiSlVKWFJiY3FTX1RVLVg1ZHJVSFVYNU1MSS1pc01NOFE2NVZhZHhVVDUxZTVKWmU0SEVWVG9hRW10T3lZZVhLQ1kzODR2T0Z4QncyaGFyVWlNTzdzcWpMMTRUbU9kUU1xVm56VnE0cGVxNzRLQlA5aGdJYmoxbnNUQ3BmWXRJ?oc=5","date":"2026-04-07","type":"regulatory","source":"Barchart.com","summary":"Epilepsy Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Aquestive Therapeutics, Atnahs Pharma (Pharmanovia), Jazz Pharma, SK Biopharma - Barc","headline":"Epilepsy Pipeline 2026: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Aques","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxQdUJ2Si1MZVg5VEN4cGxJQWhHam9GT2NnSERYeWJXZG5hV1lCOXpfYUlBRmhDZEhBSnJjbWxvNnJPSEFBd1MtQndEWVplM3AxWEF4Mk1QV1k4dVlINGlQMFVmOXhNWGl1eFd3WWZGUFNrbnZSRGJhaGtYNC1YdVcxUVpNWDZnN0JkdDhVS254TTAtdG5zbndJUzBJak0wczhFWFV5ZUJZcjlmSGg3YjkwcThjVExTZEJuV05UMzFkdVRJWU9XTlA1eDhBclFLR0VjR2ZHSUFIaDQ1d00tVHpVSDl6OU5lMm8tZGtkUTZObXp0OVN6YjRPNDRjTXM1ZFFjdHpvTUI3VXl2TW1yUFNKNjZQQmo3aGp3MmNocWE1ZVJ0TF9DXzNtWGhZZ0tJZUdocldjajhoZlFLbEpYaFo5blJPeU9OV2hLaEhSWmxZeldqWW5kc3VF?oc=5","date":"2026-03-26","type":"pipeline","source":"GlobeNewswire","summary":"Achieve Life Sciences Announces Publication in Nicotine & - GlobeNewswire","headline":"Achieve Life Sciences Announces Publication in Nicotine &","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPR2h6bGk5bE9iT2tUVkhKemFKaW5jOVRfTE9kQV9Sc2tINjlyWjZCbzFwdlN6YU5OZDd3TlZhT1haWnZqQi1pdk56dVRvTUQxWERiTUM1blEyWDdMSXhKT3kzaTc5Ykp1M1h2SXVhc2puTFhoTWdmMHRDYnd1aXdENE03c2o4Rmh3UGlfaF9NQk0yRU5TaHVNaGlvdlRxeEdZUlVKMmo1UHQ0aVFHdGhacl83MzRLVkNIVDZKR0lwZ0o?oc=5","date":"2026-03-09","type":"trial","source":"TechTarget","summary":"Regeneron's GLP-1/GIP obesity drug succeeds in late-stage trial - TechTarget","headline":"Regeneron's GLP-1/GIP obesity drug succeeds in late-stage trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOVlh0OGRZb3FJRGZPT1NBRkw4X0NaOFlKVGh1LU5Mcmo0SHo1b3gtLVpsdWdYTC1KRWNVVmpWdm5UbEVFTkRZVExOU1BvMkxUWDBMTkRNSmdpWDdyQ3hacXNYUnAxb2hxUEUxanQ0SHg5VlJRcFdFRUl4RUtkQlR0WVctelJmYTY5X3FnQ25xdW0tazlmR19xMllzcU5xRjZHelNOWnZ1ZUZHZ2ZwbVppYlBR?oc=5","date":"2026-01-27","type":"trial","source":"Pharmaceutical Executive","summary":"Roche Reports Positive Phase II Study Results for Dual GLP-1/GIP Receptor Agonist | PharmExec - Pharmaceutical Executive","headline":"Roche Reports Positive Phase II Study Results for Dual GLP-1/GIP Receptor Agonist | PharmExec","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOa20tdFRnZm5iX3YxQjg5clNOR1pRdzlGYlRSUWhMUjhqMXp4OEp4TG5YM3BYa08zYl9KVUxTQ2RUY3ZXQ3pmRHFpZEtCNl9YYzF6UWctQS1IczJqNHVPSjl3TDh0WXFhWUY2LUNVQVRmRUxpY3dDZW9TZXdQNE5yZS1wWU1Ga2d3dmJxVmVnTDhfWlMwaVg4?oc=5","date":"2026-01-13","type":"pipeline","source":"Asia Research News |","summary":"Uncovering a Hidden Mechanism in Met Receptor Activation - Asia Research News |","headline":"Uncovering a Hidden Mechanism in Met Receptor Activation - Asia Research News |","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOQkxmbk12TjRSRXhEVnFZTGotcy1sUlZsYXdPSTNBeV9BTk40QnJraDBzeHppNGpuR0JLVmk3TV82a0drdXhTdUpGOTgzMk5DbVdlclZYMTQzSzlfelE1eTdwYXpGVXBNMzV6eW05ZjBPLTFTMHF5TUNscEVlTkhqWQ?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds - Fierce Biotech","headline":"Fierce Biotech Fundraising Tracker '25: Atavistik adds $120M; Syneron Bio secures new funds","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQS1VHdUdiMXFwWk5PU1NJc2k3dE9JeU84MmtYMlpONE9udUhzTEZLQ29iS2pEcm5Nbkw4bkhnclFhUXdrWFJ5ZURCX3FOdUg3dWxYNFBiRTg1eUxoUFhHTF9xVTEzYnJkV2VFY3pEM25XdlBEQlhteEc2MEhuanlEQll4WV90Z1o0a3ZJYU5XMmRZWXRlMFN5enRDekxwaVpmNUFDTXo2am0?oc=5","date":"2025-12-08","type":"pipeline","source":"BioWorld News","summary":"Wave Life, Structure and Ascletis post wins in obesity management - BioWorld News","headline":"Wave Life, Structure and Ascletis post wins in obesity management","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-20","type":"pipeline","source":"prnewswire.com","summary":"Alcohol Use Disorder Market to Grow Rapidly at a 13.6% CAGR by 2034 Owing to Rising Disease Prevalence, Significant Advancements in Genetically-targeted Therapies, along with Innovative Treatments suc","headline":"Alcohol Use Disorder Market to Grow Rapidly at a 13.6% CAGR by 2034 Owing to Rising Disease Prevalence, Significant Adva","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE9BdjR3eXRaTU41dGJfN0wxWHc3UmJyUGc5SkhwUXI5czB1T05fWFdGZG1VWFRGd0dGTW9BUXhMVkkzcVhXbHBha3VhTG1fbmlCbS0yc2ZJWExscnJ5VDYxR3NlM1NnOWtJLVgzbDY2LWFhQQ?oc=5","date":"2025-11-11","type":"pipeline","source":"Labiotech.eu","summary":"Seattle top biotechs 2025: the 9 companies you should now about - Labiotech.eu","headline":"Seattle top biotechs 2025: the 9 companies you should now about","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNZkxuNVV5UW1PSDFhVjMzWk1iQVcyNUlCbHBLQV9rMldSVTVVMzRDRndKSmdGbHJBSElsNzRLaTg4N3ktcXRmVHRzWkR3VkRLbTlMdGRfNmEyTVM0VUZhNDhtWnNrcGkxeFNNSGJwYTB0U1ZjRFhHVlFMdTlXU2VyeDlYS2pvdXJidm13bDQzYnNKdEhvMmV3S18zNnQ2aDRVajQ5NWNKNjRpRnU2SlBUN2hoTDFMVWJuVGswV2tlcHdCZw?oc=5","date":"2025-10-14","type":"pipeline","source":"baincapital.com","summary":"Kailera Therapeutics Announces $600 Million Series B Financing to Further Advance Pipeline of Next-Generation Therapies for the Treatment of Obesity - baincapital.com","headline":"Kailera Therapeutics Announces $600 Million Series B Financing to Further Advance Pipeline of Next-Generation Therapies ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPQUp6UXFMeDRDXy1LNC1hSFFndGJyMks5eGlfYUxmQzJoaThOSzJNMU82YkI4ZnlIYnJkTzBvM1N2SkUxeFZPMUNBb2xZdWRxTDM5eEJlR3JrNFYxX0NfU0xGc1YzVU5xTGlmcWM1RjJ2eVpSLW9xYnJ0c0hnZGlqT2JjN0lfOFI1TnpOMXhwS0tuN19xNVdCWWRYeHdydw?oc=5","date":"2025-06-23","type":"pipeline","source":"PwC","summary":"The GLP-1 effect on MedTech | Strategy& - PwC","headline":"The GLP-1 effect on MedTech | Strategy&","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}